Medical devices company Insulet Corp. (PODD) Monday reported first-quarter net loss of $10.7 million or $0.20 per share, narrower than $14.8 million or $0.31 per share last year.
Revenues for the quarter were $57.36 million, up 20% from $47.75 million a year ago.
Analysts polled by Thomson Reuters estimated a loss of $0.21 per share on revenues of $57.26 million for the quarter. Analysts' estimates typically exclude special items.
Looking ahead to the second quarter, the company expects revenues of $59 million to $62 million, while analysts currently expect revenues of $60.99 million.
For fiscal year 2013, the company estimates revenues of $240 million to $255 million, while analysts currently estimate $249.11 million.
For comments and feedback: editorial@rttnews.com